FDA Releases Final Guidance on Postmarket Surveillance and Post-Approval Studies

Summary

The Food and Drug Administration (FDA) has released final guidance documents to clarify postmarket surveillance requirements and procedures for handling post-approval studies. These documents aim to increase transparency and set expectations for timely study completion.